Brief: Interpace Biosciences Announces Q1 2022 Financial And Business Results
16/05/2022 22:36
May 16 (Reuters) - Interpace Biosciences Inc IDXG.PK :
* INTERPACE BIOSCIENCES ANNOUNCES FIRST QUARTER 2022
FINANCIAL AND
BUSINESS RESULTS
* INTERPACE BIOSCIENCES INC - Q1 REVENUE OF $10.4 MILLION UP
6%
VERSUS PRIOR YEAR
Source text for Eikon: ID:nGNX5Fgdc0
Further company coverage: IDXG.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million